Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|July 2, 2020
- Pharmaceutical Technology-07-02-2020
- Volume 44
- Issue 7
Double Planetary Mixer
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system.
The Double Planetary Mixer from Ross is scalable through 1000-gallon production models and is offered in a sanitary turnkey configuration that features a stainless-steel workbench for the mixer and discharge system. The sanitary four-gallon Double Planetary Mixer & Discharge System Model DPM/DS-4S (pictured) includes interior and exterior stainless-steel, and type 316 surfaces with an electropolished, 150-grit finish. The mixer’s jacketed mixing vessel and high viscosity blades are equipped to produce thick gels, pastes, putties, and other semi-solids under specific temperatures, and its sealed gearbox and stirrer shafts help ensure complete cleanability and eliminate cross-contamination between batches.
Articles in this issue
about 6 years ago
Qualification of a Swab-Sampling Procedure for Cleaning Validationabout 6 years ago
Performing Remote Audits During the Pandemicabout 6 years ago
Demand for Custom Dosage Forms Fuels Innovationabout 6 years ago
Learning Regulatory Lessons in Times of a Crisisabout 6 years ago
Business on Hold? EMA’s Full Recovery in Questionabout 6 years ago
Taking a Controlled Approachabout 6 years ago
Unprecedented Times in Vaccinesabout 6 years ago
No Business, Like Brexit Businessabout 6 years ago
Innovating Continuous Twin-Screw Granulation with Foam DeliveryRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
3
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
4
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
5